reports
MedX to Present at Benzinga Healthcare Conference on September 30th
Mississauga, Ontario--(Newsfile Corp. - September 29, 2021) - (TSXV: MDX) ("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce its participation in the Benzinga Healthcare Small Cap Conference (the "Conference"), taking place virtually on Thursday, September 30th at 4:40 PM ET. MedX President & CEO, Sylvain Desjeans, along with Mike Druhan, President Dermatological Services, will present the Company's vision for scaling access to its unique dermatological image capture technology and fully integrated telemedicine platform, DermSecure®. The screening platform ...
MedX Health Corp.’s SIAscopy Technology Being Introduced to the Span...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced that it has shipped an initial order in excess of $120,000 of its SIAscopy technology to Spain through its marketing partnership with OncoTech LLC. “Completing this large order early in the second quarter reinforces the growing interest in our technology as a pain-free non-invasive skin assessment tool,” noted Rob von der Porten, MedX's CEO. “OncoTech sees this as a first step in gaining awareness followed by further market penetration i...
MedX Health Corp. Announces 2017 Year End Results and Granting of Shar...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2017, which are also available on SEDAR (www.sedar.com). The Company reported revenue of $1,093,239 for the year ended December 31, 2017, an increase of 34% from revenue of $817,055 for the year ended December 31, 2016. Sales from the Company's therapeutic laser line grew by $341,488 during 2017, while revenue from SIAscopy, the Company’s skin assessment technology, was $65,304...
MedX Health Corp. Adds Experienced Medical Device Professional, Scott ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that Scott Spearn, an experienced medical device executive, joined the MedX team as President. Mr. Spearn has successfully built sales and distribution channels for medical devices across Canada, the United States and Latin America. His focus will be on developing and expanding MedX’s North American and international sales. Mr. Spearn will report to Robert von der Porten, CEO. “With the completion of successful financings and the f...
MedX Health Corp. Announces Investor Relations Agreement
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V:MDX). The Company announces that it has received notice from the TSX-V accepting an Investor Relations Agreement entered into with Mi3 Communications Financières Inc. (the “Consultant”) with an effective date of December 1, 2017. Under the terms of the Agreement, the Consultant will carry out activities to develop the Eastern Canada shareholder base of the Company, and the Company will pay to the Consultant a monthly consideration of $5,000, tog...
MedX Health Corp. Announces Regulatory Clearance for its SIAscopy Medi...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today it has received regulatory clearance from the New Zealand Medicines and Medical Devices safety authority (Medsafe WAND) to sell its SIAscope medical device in New Zealand. New Zealand has the highest rate of melanoma skin cancer in the world – eclipsing Australia as the most dangerous place to be exposed to the sun, according to new research published in the Journal of Investigative Dermatology. “MedX believes it can greatly reduce...
MedX Receives Corporate Citizenship Award from the Melanoma Network of...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that it received a Corporate Citizenship Award from the Melanoma Network of Canada (“MNC”) for MedX’s work in raising melanoma awareness. Alexa Cain, Executive Director of MNC, and Don Fernald, a Director on MNC’s Board, presented a plaque and a glass sculpture, designed by acclaimed Canadian artist Paull Rodrigue, to the MedX team at MedX’s offices in Mississauga. “The support from MedX has been truly amazing and inspirin...
MedX Health Corp. Announces SIAscopy Order Exceeding $100,000 for Spai...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce that it received an initial order in excess of $100,000 for its pain-free, non-invasive skin assessment SIAscopy technology for use in Spain through its marketing partnership with OncoTech LLC. In May 2017, MedX announced that OncoTech, a US-based company which has built strong business relationships in Spain, Mexico and Colombia, would help MedX establish and grow sales in these Latin countries. “We are very pleased by this...
MedX Health Corp. Announces Proposed Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announces that it intends to raise up to a further $1,500,000 from accredited investors, by issuance of up to 12,500,000 Units, at $0.12 per Unit. Upon closing, this proposed placement will complete the amount of the financing originally announced in March, 2017, at which time the proposed placement was being offered on a brokered basis. The current portion of the proposed financing is being offered by the Company on a non-brokered basis b...
MedX Health Corp. Announces Closing of Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX). The Company announces that, effective December 15, 2017, it closed a non-brokered private placement. On Closing of the placement, the Company raised gross proceeds of $725,679 to its treasury by issuance of 6,047,329 Units, comprising 6,047,329 common shares (“Share(s)”) and 6,047,329 share purchase warrants (“Warrants”) at $0.12 per Unit. Each Warrant entitles the holder to purchase one additional Share during the period expiring Decembe...
MedX Health Corp. Announces Revenue Growth in its Third Quarter 2017 R...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the three and nine months ended September 30, 2017, which are also available on SEDAR (www.sedar.com). The Company reported revenue of $255,269 for the three months ended September 30, 2017, a 5% increase over revenue of $243,287 for the three months ended September 30, 2016. Sales from the Company's therapeutic laser line showed continued strength; revenue from its SIAscopy products were relatively uncha...
MedX Health Corp. Announces Launch of Skin Scanning Service in the Net...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce that its channel partner, Nationale Healthcheck (“NH”), has launched its skin assessment service using SIAscopy in the Netherlands. NH has commenced the installation of its proprietary diagnosis and triage system addressing selected illnesses including cardiac disease, diabetes, skin cancer and Post Traumatic Stress Disorder (“PTSD”). NH has selected MedX’s SIAscopy technology for its skin assessment module with remote diagn...
MedX Health Corp. Announces the Addition of Two Renowned International...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce that Dr. Per Hall and Dr. Joe Walls, internationally renowned for their research on skin cancers and published authors of peer-reviewed research papers, have joined its Medical Scientific Advisory Board. “We are very pleased to have Dr. Hall and Dr. Walls join our Medical Scientific Advisory Board. Both have been highly supportive of efforts in the early detection of skin cancers and of SIAscopy; their insights and guidance ...
MedX Health Corp. and Blanc Labs Complete Design of Cloud-Based Teleme...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce that it has completed the design phase of its telemedicine platform which will allow MedX’s scanning devices to be deployed in multiple points of service in North America and internationally. The scanned images will be sent securely to dermatologists for remote assessment, allowing for accelerated referral for patients to an in-person consultation with a dermatologist for the treatment of suspicious cases. “We are very excit...
MedX Health and Calian’s Primacy Management Join Together to Provide...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) notes that despite unusually sweltering heat in Toronto, hundreds of people participated in the Strides for Melanoma Walk for Awareness on Sunday, September 24 in Sunnybrook Park. The annual event, which included concurrent 5Km walks in cities across Canada, is a key fundraiser organized by the Melanoma Network of Canada (“MNC”), a national skin cancer patient advocacy and educational network. The MNC is collaborating with MedX to create an early ...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.